Preclinical studies suggest ivermectin may be effective against some cancer cell lines in high doses, Johnson said. In a 2021 ...

New Combination Drug Therapy Shows Promise for Advanced Melanoma PatientsThe Mountain West has the one of the highest rates of melanoma in the nation ...

Huntsman Cancer Institute’s work proves that exercise isn’t optional—it’s a powerful part of cancer recovery,” says Neli Ulrich, PhD, MS, chief scientific officer and executive director ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Her time at Mass General Hospital and Harvard University deepened her interest in cardiovascular comorbidities, including diabetes, and how they affect people with cancer. She credits her mentor, Neli ...

Skin cancer is one of the most common cancers in America, but there are steps you can take to lower your risk. Dermatologist ...

Responses in Utah to passage of H.R. 1 fell along party lines, with Utah Democrats condemning the cost and impact of the Act.

And that is beautiful, to think that you helped to make that true,” says Soares. The Takeaway Misconceptions about cancer clinical trials persist and lead to a reluctance to participate.

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

Trial sites in the U.S. include UCLA, UC Irvine, University of Iowa, University of New Mexico, Montefiore Medical Center, Huntsman Cancer Institute at University of Utah and VCU Massey Cancer Center.